Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer

por Kim, Seung Tae, Jang, Kee-Taek, Lee, Jeeyun, Jang, Heung-Moon, Choi, Hye-Jin, Jang, Hye-Lim, Park, Se Hoon, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki, Park, Joon Oh
Publicado 2015